Medovex Corporation Completes Phase II CE Mark Audit with Notified Body LNE/GMED

ATLANTA, GA–(Marketwired – Feb 15, 2017) – Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that the Company successfully completed its final CE Mark audit meeting. The review of the Company’s DenerveXT System was conducted February 7-9, 2017 by LNE/GMED, a French-based Notified Body firm. This audit is required to demonstrate compliance with the regulatory requirements to achieve CE Mark approval.